{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:40:01Z","timestamp":1756366801392,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"abstract":"<jats:p>Thyrotropin (TSH)-secreting pituitary adenomas (TSHomas) are rare tumours. It has been suggested that thyroid surgery or radioiodine treatment should not be considered in patients with such tumours as these treatments may facilitate rapid tumour expansion. We studied the effects of thyroid ablative treatment on tumour size and thyroid status in two patients with TSHomas. Patients studied were: (1) a female with a TSHoma who declined to undergo pituitary surgery and underwent a total thyroidectomy instead and (2) a male patient who opted for radioiodine treatment for his recurrent TSHoma. Changes in tumour size on serial magnetic resonance imaging scans, and restoration of euthyroidism were studied. No marked changes in tumour size or features of aggressiveness occurred in these patients over periods of 8 and 12 years. Euthyroidism was restored and maintained in both patients. Ablative thyroid treatment can be a safe and successful option to treat TSHomas.<\/jats:p>","DOI":"10.1136\/bcr.07.2008.0541","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T13:33:18Z","timestamp":1232717598000},"page":"bcr0720080541","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Ablative thyroid treatment for thyrotoxicosis due to thyrotropin-producing pituitary tumours"],"prefix":"10.1136","volume":"2009","author":[{"given":"C","family":"Daousi","sequence":"first","affiliation":[{"name":"Clinical Sciences Centre, Lower Lane, Liverpool, L9 7AL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M","family":"Foy","sequence":"additional","affiliation":[{"name":"The Walton Centre For Neurology & Neurosurgery, Lower Lane, Liverpool, L9 7AL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian A","family":"Macfarlane","sequence":"additional","affiliation":[{"name":"University Hospital Aintree, Diabetes & Endocrinology Clinical Research Group, Clinical Sciences Centre, Liverpool, L9 7AL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-17-6-610"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2265.1994.tb02480.x","article-title":"Hyperthyroidism secondary to a pituitary adenoma secreting TSH, FSH, alpha-subunit and GH","volume":"40","author":"Patrick","year":"1994","journal-title":"Clin Endocrinol (Oxford)"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.3","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-3-199308010-00010"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2265.1994.tb03941.x","article-title":"Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas","volume":"40","author":"Gancel","year":"1994","journal-title":"Clin Endocrinol (Oxford)"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJM198707023170103","article-title":"Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue","volume":"317","author":"Comi","year":"1987","journal-title":"N Engl J Med"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.4.1487"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.6.2849"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/thy.2000.10.1001","article-title":"Treatment of a thyrotropinoma with octreotide-LAR in a patient with multiple endocrine neoplasia-1","volume":"10","author":"Taylor","year":"2000","journal-title":"Thyroid"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.9","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-1-208"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.2.476"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.11","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.0990224"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-59-5-817"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF03351008","article-title":"Regulation of hormone release by cultured cells from a thyrotropin-growth hormone-secreting pituitary tumor. Direct inhibiting effects of 3,5,3\u2032-triiodothyronine and dexamethasone on thyrotropin secretion","volume":"7","author":"Lamberts","year":"1984","journal-title":"J Endocrinol Invest"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.14","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1300559"},{"key":"2025082800032250000_2009.aug06_1.bcr0720080541.15","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(93)90257-K"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr.07.2008.0541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:03:27Z","timestamp":1756364607000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr.07.2008.0541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":15,"alternative-id":["10.1136\/bcr.07.2008.0541"],"URL":"https:\/\/doi.org\/10.1136\/bcr.07.2008.0541","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}